Is Corvus Pharmaceuticals, Inc. (CRVS) a Buy, Sell, or Hold?
NASDAQ : CRVS
Corvus Pharmaceuticals, Inc. — Analyst Ratings
$12.92 USD
-$0.15 (-1.15%)
- Volume
- 822.34K
- Average Volume
- 1.48M
- Market Capitalization
- $1.09B
- P/E Ratio
- -23.49
- Dividend Yield
- 0.00%
- Price Target
- $35.00
- Year High
- $26.95
- Year Low
- $3.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.81
Analyst Consensus Summary
Consensus Rating
Sell
13 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-63.1%
vs Current Price
Price Target
$35.00
Average TargetPrice Target Range
Lowest Target
$30.00
-56.9% DOWNSIDE
Average Target
$35.00
Median Estimate
Highest Target
$40.00
-67.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 13
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 12 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Mizuho Securities | Graig Suvannavejh | $30 | $20.54 | 2026-01-29 06:45 AM | 46.1% |
| Jefferies | Roger Song | $42 | $25.8 | 2026-01-22 12:28 PM | 62.8% |
| H.C. Wainwright | Sean Lee | $27 | $18.22 | 2026-01-20 11:00 AM | 48.2% |
| Mizuho Securities | Graig Suvannavejh | $11 | $3.68 | 2025-05-20 07:41 AM | 198.9% |